Impact of D-dimer level on postinterventional coronary flow and in-hospital MACE in ST-segment elevation myocardial

B Sarli1, M Akpek, A O Baktir

  • 1Department of Cardiology, Kayseri Education and Research Hospital, 38010, Kayseri, Turkey, drsarli@yahoo.com.

Herz
|January 21, 2014
PubMed

Insights

Elevated D-dimer levels in ST-elevated myocardial infarction (STEMI) patients predict no-reflow and adverse cardiovascular events after percutaneous coronary intervention (PCI). This finding aids in risk stratification for STEMI outcomes.

Area of Science:

  • Cardiology
  • Biomarkers
  • Interventional Cardiology

Background:

  • Preintervention thrombus burden impacts outcomes in coronary artery disease.
  • The role of D-dimers in ST-elevated myocardial infarction (STEMI) during primary percutaneous coronary intervention (PCI) requires further elucidation.

Purpose of the Study:

  • To investigate the predictive value of serum D-dimer levels for outcomes in STEMI patients undergoing primary PCI.
  • To assess the association between D-dimer levels and postinterventional no-reflow and major adverse cardiovascular events (MACE).

Main Methods:

  • A cohort of 266 STEMI patients within 12 hours of symptom onset were analyzed.
  • Patients were stratified into no-reflow (TIMI grades 0-2) and TIMI 3 flow groups post-PCI.
  • Multivariate logistic regression and ROC analyses were performed to evaluate D-dimer's predictive capacity.

Main Results:

  • D-dimer levels were significantly higher in the no-reflow group compared to the TIMI 3 flow group (686 vs. 418 μg/ml, p < 0.001).
  • Serum D-dimer independently predicted postinterventional no-reflow (OR: 1.005; p < 0.001) and in-hospital MACE (OR: 1.002; p = 0.029).
  • Optimal D-dimer cut-off values were identified for predicting no-reflow (549 μg/ml) and MACE (544 μg/ml).

Conclusions:

  • Serum D-dimer levels on admission are an independent predictor of no-reflow in STEMI patients.
  • No-reflow is itself a predictor of adverse outcomes, highlighting D-dimer's prognostic significance in STEMI management.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749